CD274 and non-small cell lung carcinoma: In less heavily pretreated non-squamous NSCLC patients, median OS has ranged from 8.0 to 12.2 months for single-agent chemotherapy and from 9.4 to 15.6 months for anti-PD1/PD-L1 therapy [4, 5, 7, 11, 25].